Conclusions are great and albeit only the opinion of the person making such. Bottom line is the company is the owner of patents.
Montano's company press release speculates that their drug MAY be effective and easy to realize it is an attempt to gain investors once they are allowed to go public.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.